Literature DB >> 1868911

Serum cobalamins in the elderly: a longitudinal study of a representative population sample from age 70 to 81.

H Nilsson-Ehle1, R Jagenburg, S Landahl, S Lindstedt, A Svanborg, J Westin.   

Abstract

In a representative population sample (n = 973) born 1901-1902 and examined at the ages of 70, 75, 79, and 81, the change in serum cobalamins with increasing age was studied by trend analysis using values obtained in single individuals at all four examinations. In subsamples without definable disorders, the mean annual decline was: among men 3.4 pmol/l (p less than 0.05), among women 3.2 pmol/l (n.s.). The decline was possibly more pronounced among individuals with low and intermediate concentrations. The health-related lower reference limits (the 2.5 percentile values of subsamples without definable disorders) did not differ significantly between sexes and age groups, but low concentrations or ongoing cobalamin medication became more common with advancing age. The results indicate a slight fall in serum cobalamins between age 70 and 81 but do not call for age-related lower reference limits.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1868911     DOI: 10.1111/j.1600-0609.1991.tb00555.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  5 in total

1.  Gastric status and vitamin B12 levels in cardiovascular patients.

Authors:  Martijn G H van Oijen; Pentti Sipponen; Robert J F Laheij; Freek W A Verheugt; Jan B M J Jansen
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.199

Review 2.  Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy.

Authors:  H Nilsson-Ehle
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

3.  Serum concentrations of vitamin B12 and folate in British male omnivores, vegetarians and vegans: results from a cross-sectional analysis of the EPIC-Oxford cohort study.

Authors:  A M J Gilsing; F L Crowe; Z Lloyd-Wright; T A B Sanders; P N Appleby; N E Allen; T J Key
Journal:  Eur J Clin Nutr       Date:  2010-07-21       Impact factor: 4.016

4.  Vitamin B12 measurements across neurodegenerative disorders.

Authors:  Nijee S Luthra; Ariane H Marcus; Nancy K Hills; Chadwick W Christine
Journal:  J Clin Mov Disord       Date:  2020-03-12

5.  Relationship of Cerebrospinal Fluid Vitamin B12 Status Markers With Parkinson's Disease Progression.

Authors:  Chadwick W Christine; Peggy Auinger; Nasrin Saleh; Miao Tian; Teodoro Bottiglieri; Erland Arning; Nam K Tran; Per Magne Ueland; Ralph Green
Journal:  Mov Disord       Date:  2020-05-14       Impact factor: 10.338

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.